We knocked down EMSY in OVCAR3, an ovarian cancer cell line with EMSY amplification, and measured RAD51 foci formation upon treatment with camptothecin (CPT), an inhibitor that targets DNA topoisomerase I resulting in collapse of the replication fork and DNA double-strand breaks (Supplementary Figure 1). Here, RAD51 is linked to ovarian cancer.